Emcure Pharmaceuticals to Fully Acquire Zuventus Healthcare

💊

will acquire the remaining 20.42% stake in Zuventus Healthcare for ₹724.9 crore, making it a wholly owned subsidiary. The deal is expected to close in Q2 FY26, strengthening Emcure's control and integration of its healthcare operations.